glp 1 treatment diabetes Glucagon-like peptide-1 Another milestone in the evolution

[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Nauck MA, et al

Diabetologia (2003) 46:22230

While this medication shares the same active ingredient with Zepbound, the latter is specifically approved for chronic weight management

Hepatic steatosis and liver enzymes were successfully reduced by the injection of FGF analogs

2025 Dec;222:108045

| | Europe/North America | Stringent regulatory standards (FDA, EMA), innovation, complex synthesis, strong IP protection | High-purity APIs, novel compounds, R&D partnerships | Advanced liquid-phase peptide synthesis (LPPS), continuous flow chemistry for complex peptides, specialized chiral synthesis